Vector control portfolio protected millions of lives in 2012 / Important role of public-private partnerships and research collaborations / Training and education of local communities
Monheim, April 25, 2013 –
Malaria is still one of the major causes of mortality and morbidity in the world today. With its global research and development activities and its broad portfolio of innovative solutions, Bayer CropScience contributes to the fight against malaria. The company has been a leader in malaria prevention for over 50 years and offers a unique and comprehensive vector control portfolio.
“Malaria is still too often a question of life or death, especially for children under the age of five. Our commitment to Research & Development has provided the technology and expertise behind products that protect millions of people in Africa and across the world today,” said Dr. Gunnar Riemann, Member of the Executive Committee of Bayer CropScience and President of the Environmental Science Division. “By providing our considerable history and expertise in all four areas of vector control – water, air, surfaces and personal protection – we help make a lasting and sustainable impact on the rural development of local communities, in line with our mission – Bayer: Science For A Better Life.”
Another reason why Bayer CropScience is committed to playing an ongoing leading role in the fight against this preventable tropical disease is that agriculture is not exempt from malaria’s devastating impact. With 80 percent of the world’s famers living in malaria-endemic regions, the disease has a significant impact on the availability of labor for both small and large-scale farming and food security, and is thus a major contributing factor to poverty.
Supporting integrated vector management
Bayer CropScience offers a range of vector control solutions suitable for integrated vector control and also provides expertise to support the development of local communities in Africa through education and training in the correct use of vector control products. This includes specially developed cartoon booklets aimed at teaching children how to use bed nets, avoid being bitten by mosquitoes and recognize the early signs of malaria. ‘Train the trainer’ sessions, in particular, ensure that national malaria programs have the capacity and knowledge to develop effective intervention teams throughout their countries.
The portfolio is built around a range of vector control products suitable for complementary use as indoor residual sprays, long-lasting insecticide-treated bed nets and larvicides. One of Bayer CropScience’s key brands is Ficam™, a World Health Organization Pesticide Evaluation Scheme (WHOPES)-recommended indoor residual spray regarded as an important tool in resolving mosquito resistance to pyrethroid-based insecticides. In 2012, Ficam™ was used in the protection of millions of lives in Africa. Another recent example of Bayer CropScience’s continued commitment in the fight against malaria is the development of LifeNet™, one of the most significant innovations on the long-lasting insecticide treated bed net market for some 15 years.
The power of public-private partnerships
Bayer CropScience believes that the power of public-private partnerships is key in the global fight against malaria. “Only through close collaboration between the people who rely on our products and our expertise, national malaria programs and international donor organizations can the full benefit of our solutions be realized,” pointed out Riemann. “We believe it is essential to actively involve all our stakeholders in dialogue and joint projects.” The company is an active member of the international malaria community and is represented in numerous working groups, including the World Health Organization (WHO) malaria policy group and working groups on neglected tropical diseases, integrated vector management and long-lasting insecticidal nets.
Furthermore, in 2012 Bayer CropScience and the IVCC, Liverpool, UK, a registered charity in the field of product development and information systems for vector control, extended their research partnership for another 3 years. This collaboration addresses future vector control options by focusing on the search for a new insecticidal active ingredient that is particularly effective against resistant mosquito strains.
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. This year the company looks back on 150 years of working to fulfill its mission “Bayer: Science For A Better Life.” Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
Note to editors:
A photo in print quality can be downloaded from the internet at www.press.bayer.com and www.press.bayercropscience.com.
Find more information at www.bayercropscience.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.